Reata pharmaceuticals, inc. (RETA)
Balance Sheet / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Dec'15Dec'14
Assets
Cash and cash equivalents

624,488

664,324

240,149

280,449

313,056

337,790

375,185

138,676

105,937

129,780

154,600

65,176

82,676

84,732

95,660

92,365

42,008

87,758

Current portion of deferred tax asset

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2,287

Prepaid expenses and other current assets

5,150

4,952

6,382

6,762

4,416

4,483

4,633

3,284

2,489

3,329

3,246

3,713

3,041

2,551

4,260

3,389

3,325

1,413

Receivables from collaboration arrangements

-

-

-

-

-

-

-

30,452

26,321

-

-

-

-

-

-

-

-

-

Income tax receivable

22,218

-

-

-

-

-

-

-

-

-

-

-

-

-

-

17,170

31,926

15,243

Total current assets

651,856

669,276

246,531

287,211

317,472

342,273

379,818

172,412

134,747

133,109

157,846

68,889

85,717

87,283

99,920

112,924

77,259

106,701

Property and equipment, net

3,898

2,996

2,859

2,814

2,693

1,445

795

810

829

718

774

671

703

819

899

942

1,142

2,516

Deferred tax asset, net of current portion

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

15,515

Other assets

8,443

10,148

9,733

10,463

11,120

1,490

1,496

1,497

1,237

1,510

1,760

1,760

1,760

991

1,004

554

553

872

Total assets

664,197

682,420

259,123

300,488

331,285

345,208

382,109

174,719

136,813

135,337

160,380

71,320

88,180

89,093

101,823

114,420

78,954

125,604

Liabilities and stockholders’ equity (deficit)
Accounts payable

12,627

1,908

3,582

4,361

3,500

4,473

5,000

2,113

1,002

2,067

2,527

2,670

541

3,830

1,296

1,552

3,531

765

Federal income tax payable

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,220

Accrued direct research liabilities

19,906

23,774

19,848

20,871

16,263

15,416

18,449

15,334

13,830

12,627

10,014

7,491

5,443

6,151

4,424

4,205

3,975

3,599

Other current liabilities

13,606

11,631

14,398

11,056

10,107

4,696

8,083

8,130

5,005

3,511

6,474

5,198

3,885

3,047

4,756

4,649

3,584

2,919

Current portion of payable to collaborators

150,000

150,000

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Current portion of long-term debt, net of debt issuance cost

-

-

5,313

-

-

-

-

-

2,693

1,229

-

-

-

-

-

-

-

-

Current portion of deferred revenue

4,701

4,701

31,421

31,421

31,335

31,335

31,335

30,157

28,836

28,183

30,588

35,985

41,323

46,603

49,595

49,595

49,730

49,595

Total current liabilities

200,840

192,014

74,562

67,709

61,205

55,920

62,867

55,734

51,366

47,617

49,603

51,344

51,192

59,631

60,071

60,001

60,820

58,098

Other long-term liabilities

7,245

6,982

6,198

7,594

8,472

524

531

1,039

46

53

7

29

51

72

94

116

249

981

Term loan, net of current portion and debt issuance costs

155,506

155,017

74,923

79,897

79,558

79,219

78,881

78,591

16,977

18,385

19,833

19,792

19,753

-

-

-

-

-

Payable to collaborators, net of current portion

68,440

66,862

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Deferred revenue, net of current portion

3,519

4,688

170,863

178,761

186,660

194,386

202,285

207,229

211,125

216,255

223,359

230,463

237,489

244,438

253,947

266,447

291,041

340,771

Total noncurrent liabilities

234,710

233,549

251,984

266,252

274,690

274,129

281,697

286,859

228,148

234,693

243,199

250,284

257,293

244,510

254,041

266,563

291,290

341,752

Commitments and contingencies

-

-

-

-

-

-

-

-

-

-

0

0

0

0

0

0

0

0

Stockholders’ (deficit) equity:
Additional paid-in capital

988,046

967,317

456,097

450,354

444,837

435,452

432,273

196,013

192,962

190,145

188,030

77,837

76,252

74,298

72,987

72,235

10,036

7,722

Shareholder notes receivable

-

-

-

-

-

-

-

-

2

2

15

15

15

15

81

81

81

307

Accumulated deficit

-759,432

-710,493

-523,551

-483,857

-449,477

-420,323

-394,758

-363,913

-335,688

-337,143

-320,463

-308,153

-296,565

-289,354

-285,218

-284,321

-283,127

-281,677

Total stockholders’ equity

228,647

256,857

-67,423

-33,473

-4,610

15,159

37,545

-167,874

-142,701

-146,973

-132,422

-230,308

-220,305

-215,048

-212,289

-212,144

-273,156

-274,246

Total liabilities and stockholders’ equity

664,197

682,420

259,123

300,488

331,285

345,208

382,109

174,719

136,813

135,337

160,380

71,320

88,180

89,093

101,823

114,420

78,954

125,604

Common Stock A
Common stock value

28

28

25

24

24

24

24

20

20

20

-

-

-

-

-

-

-

-

Total stockholders’ equity

28

28

25

24

24

24

-

-

-

20

-

-

-

-

-

-

-

-

Common Stock B
Common stock value

5

5

6

6

6

6

6

6

7

7

-

-

-

-

-

-

-

-

Total stockholders’ equity

5

5

6

6

6

6

-

-

-

7

-

-

-

-

-

-

-

-